Regeneron Pharmaceuticals, Inc. has a market capitalization of 38934.64, with a return on assets (ROA) of 13.00% and an earnings per share (EPS)Â …
12
Dec
Leave a Reply
You must be logged in to post a comment.
Regeneron Pharmaceuticals, Inc. has a market capitalization of 38934.64, with a return on assets (ROA) of 13.00% and an earnings per share (EPS)Â …
You must be logged in to post a comment.